| Company | IgA | IgG | IgM | Rmarks |
|---|---|---|---|---|
| Aesku.Diagnostics | Cardiolipin-A | Cardiolipin-GM | Cardiolipin-GM | Method: EIA Assay principle: Two step Coating: Native human ß2-glycoprotein I + cardiolipin Entity: Qualitative and quantitative |
| Aesku.Diagnostics | Cardiolipin-Check | Cardiolipin-Check | Cardiolipin-Check | Method: EIA Assay principle: Two step Coating: Native human ß2-glycoprotein I + cardiolipin Entity: Qualitative and quantitative |
| AIDA | Cardiolipin Ig | Method: EIA Assay principle: Two step Coating: Native human ß2-glycoprotein I + cardiolipin Entity: Qualitative and quantitative | ||
| Bio-Rad | Anti-Cardiolipin | Anti-Cardiolipin | Anti-Cardiolipin | Method: EIA Assay principle: Two step Entity: Semi-quantitative |
| Bio-Rad | BioPlex 2200 APLS IgA | BioPlex 2200 APLS IgG | BioPlex 2200 APLS IgM | Method: Bioplex (beats) immuno assay
Assay principle: A two step simultaneous detection of two auto antibodies Coating: anti-Cardiolipin and anti-Beta-2 Glycoprotein I Entity: Quantitative |
| Cambridge Life Sciences | AUTOZYME ACL | AUTOZYME ACL | AUTOZYME ACL | Method: EIA Assay principle: Two step Coating: Native human ß2-glycoprotein I cofactor+ cardiolipin. Entity: Quantitative |
| Dialab | Anti-Cardiolipin IgA | Anti-Cardiolipin IgG/IgM | Anti-Cardiolipin IgG/IgM | Method: EIA Assay principle: Two step Entity: Quantitative |
| Dialab | Anti-Cardiolipin Screen | Anti-Cardiolipin Screen | Anti-Cardiolipin Screen | Method: EIA Assay principle: Two step Entity: Semi-Quantitative |
| Diamedix | Immunosimplicity anti-Cardiolipin IgA Test Kit | Immunosimplicity anti-Cardiolipin IgG/IgM Test Kit | Immunosimplicity anti-Cardiolipin IgG/IgM Test Kit | Method: EIA Assay principle: Two step Entity: Semi-quantitative |
| Diamedix | Immunosimplicity anti-Cardiolipin Screen | Immunosimplicity anti-Cardiolipin Screen | Immunosimplicity anti-Cardiolipin Screen | Method: EIA
Assay principle: Two step Entity: Semi-quantitative |
| DiaSorin | LIAISON Cardiolipin IgG | LIAISON Cardiolipin IgM | Method: CLIA
Entity: Semi-quantitative | |
| Euroimmun | cardiolipin (AMA M1) | cardiolipin (AMA M1) | cardiolipin (AMA M1) | Method: EIA
Assay principle: Two step |
| Generic | Cardiolipin antibodies – IgG,IgM | Cardiolipin antibodies – IgG,IgM | Method: EIA Assay principle: Two step Coating: Bovin Cardiolipin, human ß2 GP I Entity: Quantitative | |
| Generic | Anti-Cardiolipin Screen | Anti-Cardiolipin Screen | Anti-Cardiolipin Screen | Method: EIA Assay principle: Two step Coating: Bovin Cardiolipin, human ß2 GP I Entity: Semi-quantitative |
| Hemagen-Virgo VIRGO Cardiolipin | Virgo, Cardiolipin ELISA Test System | Virgo, Cardiolipin ELISA Test System | Virgo, Cardiolipin ELISA Test System | Method: EIA
Assay principle: Two step Entity: Quantitative |
| Hyphen BioMed | ZYMUTEST™ ACA-APA, IgG,IgM | ZYMUTEST™ ACA-APA, IgG,IgM | Method: EIA Assay principle: Two step Coating: Anionic phospholipids Entity: Quantitative | |
| IBL | Anti-Cardiolipin IgA | Anti-Cardiolipin IgG,IgM | Anti-Cardiolipin IgA IgG,IgM | Method: EIA Assay principle: Two step Coating: Cardiolipin + ß2-glycoprotein I Entity: Quantitative |
| IBL | Anti-Cardiolipin Screen | Anti-Cardiolipin Screen | Anti-Cardiolipin Screen | Method: EIA Assay principle: Two step Coating: Cardiolipin + ß2-glycoprotein I Entity: Quantitative |
| Immunodiagnosticsystems | Cardiolipin IgG | Cardiolipin IgM | Method: CLIA Entity: Quantitative | |
| Immuno Concepts | RELISA Cardiolipin | RELISA Cardiolipin | Method: EIA Assay principle: Two step Coating: Cardiolipin (from beef heart) Entity: Quantitative | |
| Imtec | Cardiolipin-Antibodies Screen | Cardiolipin-Antibodies Screen | Cardiolipin-Antibodies Screen | Method: EIA Assay principle: Two step Coating: Cardiolipin + purified human ß2-glycoprotein I Entity: Quantitative |
| Imtec | Cardiolipin-Antibodies Combi | Cardiolipin-Antibodies Combi | Method: EIA Assay principle: Two step Coating: Cardiolipin + purified human ß2-glycoprotein I Entity: Quantitative | |
| Imtec | Cardiolipin-Antibodies IgA | Cardiolipin-Antibodies IgG | Cardiolipin-Antibodies IgM | Method: EIA Assay principle: Two step Coating: Cardiolipin + purified human ß2-glycoprotein I Entity: Quantitative |
| Louisville APL Diagnostics | APL IgA ELISA Kit | APL IgG ELISA Kit | APL IgM ELISA Kit | Method: EIA Assay principle: Two step Coating: Cardiolipin + bovine ß2-glycoprotein I Entity: Semi-quantitative |
| Orgentec | Anti-Cardiolipin IgA | Anti-Cardiolipin IgG/IgM | Anti-Cardiolipin IgG/IgM | Method: EIA Assay principle: Two step Coating: Purified bovine cardiolipin + ß2-glycoprotein I Entity: Quantitative |
| Orgentec | Anti-Cardiolipin Screen | Anti-Cardiolipin Screen | Anti-Cardiolipin Screen | Method: EIA Assay principle: Two step Coating: Purified bovine cardiolipin + ß2-glycoprotein I Entity: Quantitative |
| Orgentec | Anti-Cardiolipin IgA | Anti-Cardiolipin IgG | Anti-Cardiolipin IgM | Method: EIA (Alegria) Assay principle: Two step Coating: Purified bovine cardiolipin + ß2-glycoprotein I Entity: Quantitative |
| Orgentec | Anti-Cardiolipin Screen | Anti-Cardiolipin Screen | Anti-Cardiolipin Screen | Method: EIA (Alegria) Assay principle: Two step Coating: Purified bovine cardiolipin + ß2-glycoprotein I Entity: Quantitative |
| REAADS | Anti-Cardiolipin (aCL) IgA | Anti-Cardiolipin (aCL) IgG | Anti-Cardiolipin (aCL) IgM | Method: EIA Coating: Cardiolipin Assay principle: Two step Entity: Quantitative |
| REAADS | Anti-Cardiolipin (aCL) IgG/IgM | Anti-Cardiolipin (aCL) IgG/IgM | Method: EIA Coating: Cardiolipin Assay principle: Two step Entity: Quantitative | |
| Stago | Asserachrom APA | Asserachrom APA | Method: EIA Assay principle: Two step Entity: Quantitative | |
| Stago | Asserachrom APA Screen | Asserachrom APA Screen | Asserachrom APA Screen | Method: EIA Assay principle: Two step Entity: Quantitative |
| SVAR | Cardiolipin antibodies – IgA | Cardiolipin antibodies – IgG and IgM | Cardiolipin antibodies – IgG and IgM | Method: EIA Assay principle: Two step Entity: Semi-quantitative |
| Thermo Scientific | EliA Cardiolipin IgA Well | EliA Cardiolipin IgG Well | EliA Cardiolipin IgM Well | Method: EIA Coating: Bovin cardiolipin + ß2-glycoprotein I Assay principle: Two step Entity: Quantitative |
| TheraTest | EL-aCL IgM, IgG, IgA | EL-aCL IgM, IgG, IgA | EL-aCL IgM, IgG, IgA | Method: EIA Assay principle: Two step Coating: Cardiolipin Entity: Quantitative |
| Werfen | AcuStar Anti-Cardiolipin Controls IgG | AcuStar Anti-Cardiolipin Controls IgM | Method: EIA (chemiluminescent) Assay principle: Two step Coating: Bovine cardiolipin + purified human ß2-glycoprotein I Entity: Semi-quantitative | |
| Werfen | QUANTA Flash Cardiolipin IgA | QUANTA Flash Cardiolipin IgG | QUANTA Flash Cardiolipin IgM | Method: CIA Entity: Semi-quantitative |
| Werfen | QUANTA Lite® ACA IgA III | QUANTA Lite® ACA IgG III | QUANTA Lite® ACA IgM III | Method: EIA Assay principle: Two step Coating: Purified cardiolipin + bovine ß2-glycoprotein I Entity: Semi-quantitative |
| Zeus Scientific | Cardiolipin IgA Test System | Cardiolipin IgG Test System | Cardiolipin IgM Test System | Method: EIA Assay principle: Two step Coating: Bovin heart cardiolipin Entity: Semi-quantitative |
